FALCO HOLDINGS Co., Ltd. (4671.T) JPX

Currency In JPY

AD

FALCO HOLDINGS Co., Ltd.

Address

1-3-7, Uchihiranomachi Chuo-ku

Osaka, KY 540-0037

Japan

Phone

81 75 257 8585

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

1037

First IPO Date

October 29, 2004

Key Executives

NameTitlePayYear Born
Takafumi FukuiExecutive VP, GM of Genome Business Division & Director01965
Hisayuki OhbaExecutive Officer, GM of Pharma Business Div. & Director01969
Kei ShimadaDirector, Executive Officer, Head of ICT Business Division & Deputy Head of Genome Business Division01973
Shuhei KurodaDir, Exe Officer, Head of Corporate Planning Office, Admin Office & Deputy Head of ICT Busi. Office01973
Tadashi YasudaPresident, Executive Officer & Chairman01958
AD

Description

FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.

AD